LPCN long set up

meitshel Updated   
NASDAQ:LPCN   Lipocine Inc.
No investment advice!

I do this only for practicing.

I see a cup and handle

Very nice risk / reward here.

Upcoming Catalysts:

LPCN 1144
Non-alcoholic fatty liver disease (NAFLD) / Non-alcoholic steatohepatitis (NASH)

Phase 2

Phase 2 top-line change in liver fat data met primary endpoint January 12, 2021. 36-week biopsy data are expected mid-2021.
Trade closed: stop reached:
SL hit

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.